What insider share sales did SOPHiA GENETICS (SOPH) report for its CEO?

SOPHiA GENETICS reported that CEO Jurgi Camblong sold 60,602 ordinary shares in two open-market transactions. The sales occurred on April 14 and 15, 2026, at weighted average prices of $4.9580 and $5.0021 per share, according to the Form 4 filing.

Were SOPHiA GENETICS CEO’s SOPH share sales part of a Rule 10b5-1 plan?

Yes. The Form 4 discloses that the sales were executed under a pre-established Rule 10b5-1(c) trading plan. Such plans schedule trades in advance, reducing the informational value of timing and indicating these were not ad hoc or opportunistic transactions by the CEO.

SOPHiA GENETICS (SOPH) CEO’s 60,602-share sale funds RSU tax withholding

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Executive Officer Jurgi Camblong reported routine share sales tied to tax obligations. On April 14 and 15, 2026, he sold a total of 60,602 ordinary shares in open-market transactions at weighted average prices of $4.9580 and $5.0021 per share. The filing states these sales were executed to satisfy tax withholding obligations from restricted stock units that vested on April 2 and 3, 2026, under a pre-established Rule 10b5-1(c) trading plan, meaning they were not discretionary trades. After these transactions, he continues to hold 3,646,967 ordinary shares directly.

Insights

CEO’s sales are pre-planned tax-withholding events, not discretionary selling.

The CEO of SOPHiA GENETICS SA, Jurgi Camblong, reported selling 60,602 ordinary shares at weighted average prices around $5 per share. The disclosure explains these sales funded tax withholding from recent restricted stock unit vesting, a common equity-compensation mechanism.

The filing further notes the trades were executed under a pre-established Rule 10b5-1(c) trading plan, which schedules transactions in advance and reduces their signaling value about management’s current view of the stock. Importantly, Camblong still directly holds 3,646,967 ordinary shares after these sales.

Because the transactions are both tax-driven and pre-planned, they generally represent routine administrative activity rather than a change in conviction. Subsequent company filings may provide additional context on future equity awards or further vesting-related sales.

Insider Trade Summary 10b5-1

Net Seller: 60,602 shares ($301,235)

Net Sell 2 txns

Insider Camblong Jurgi

Role Chief Executive Officer

Sold 60,602 shs ($301K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	17,473	$5.0021	$87K
Sale	Ordinary Shares	43,129	$4.958	$214K

Holdings After Transaction: Ordinary Shares — 3,646,967 shares (Direct)

Footnotes (1)

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.73 to $5.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.90 to $5.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 60,602 shares Sale price April 14: $4.9580 per share Sale price April 15: $5.0021 per share +1 more

4 metrics

Shares sold 60,602 shares Total ordinary shares sold by CEO on April 14–15, 2026

Sale price April 14 $4.9580 per share Weighted average price for 43,129 shares sold April 14, 2026

Sale price April 15 $5.0021 per share Weighted average price for 17,473 shares sold April 15, 2026

Shares held after transactions 3,646,967 shares CEO’s direct ordinary share holdings following the reported sales

Key Terms

restricted stock units, Rule 10b5-1(c) trading plan, weighted average price, open market

4 terms

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1(c) trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person"

A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.

weighted average price financial

"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market financial

"Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

Form 4 Insider Transactions: What Each Field Means →

04/16/2026 - 04:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Camblong Jurgi

(Last)

(First)

(Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE

1180

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/14/2026		S		43,129⁽¹⁾	D	$4.958⁽²⁾	3,664,440	D
Ordinary Shares	04/15/2026		S		17,473⁽¹⁾	D	$5.0021⁽³⁾	3,646,967	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.73 to $5.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.90 to $5.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

Why did SOPHiA GENETICS CEO Jurgi Camblong sell 60,602 SOPH shares?

The filing states the CEO’s share sales were to satisfy tax withholding obligations from restricted stock units that vested on April 2 and 3, 2026. This makes the transactions compensation-related and administrative, rather than discretionary portfolio or valuation-driven selling activity.

How many SOPHiA GENETICS shares does the CEO hold after these reported sales?

After the reported transactions, CEO Jurgi Camblong directly holds 3,646,967 ordinary shares of SOPHiA GENETICS. This remaining position highlights that the 60,602 shares sold represent only a small portion of his overall equity stake in the company.

What prices did SOPHiA GENETICS CEO receive for the sold SOPH shares?

The Form 4 reports weighted average sale prices of $4.9580 and $5.0021 per share for the two trading days. Footnotes explain that individual trades occurred in ranges between $4.73 and $5.18 per share, and detailed price breakdowns are available on written request.